METASTATIC HER2-NEGATIVE BREAST CARCINOMA
Clinical trials for METASTATIC HER2-NEGATIVE BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC HER2-NEGATIVE BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC HER2-NEGATIVE BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat breast cancer? scientists test Triple-Threat drug combo
Disease control OngoingThis study is testing if adding a new drug called copanlisib to the standard two-drug treatment (fulvestrant and abemaciclib) is more effective for advanced breast cancer that has stopped responding to hormone therapy. It will involve about 24 patients with hormone-positive, HER2…
Matched conditions: METASTATIC HER2-NEGATIVE BREAST CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Radioactive drug joins fight against breast cancer in bones
Disease control OngoingThis study is testing whether adding a radioactive drug called Radium-223 to standard chemotherapy (paclitaxel) works better for people with breast cancer that has spread to their bones. The radioactive drug travels to the bones and aims to kill cancer cells there, potentially sl…
Matched conditions: METASTATIC HER2-NEGATIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC